Loading…
Based on limited metadata, this Warning Letter was issued to Banco Vida Corp., a biologics manufacturer, on August 12, 2020. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA biologics regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the actual compliance concerns and required corrective actions, review of the complete Warning Letter would be necessary.